Mary L Disis

This inventor holds 28 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Cancer Vaccines. Top assignees: University of Washington, Mayo Foundation for Medical Education and Research, Pacific Northwest Research Institute. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary L Disis. Retrieved from https://idiyas.com/inventor/mary-l-disis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 8)

% Patents Active = 78.6

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 2.7

ph-index = 12

Forward Citations = 680(Granted Patents)

Location History:

Seattle, WA (US) (2020)
Renton, WA (US) (1998 - 2024)

Company Filing History:

26 out of 2,172

University of Washington

patents

5 out of 1,809

Mayo Foundation for Medical Education and Research

patents

1 out of 9

Pacific Northwest Research Institute

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Cancer Vaccines

Immune Responses

T Cell Expansion

HER-2/neu Protein

MHC Molecules

Antigen-Specific

Diagnostic Panels

Malignancies

Surface Receptor Antigens

Cancer Antibodies

Therapeutic Delivery

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622956 - METHODS AND VACCINES FOR INDUCING IMMUNE RESPONSES TO MULTIPLE DIFFERENT MHC MOLECULES (2026-05-12),

2. 12042531 - Breast and ovarian cancer vaccines (2024-07-23),

3. 11739296 - Methods and materials for expanding antigen-specific T cells in culture (2023-08-29),

4. 11464839 - Methods and vaccines for inducing immune responses to multiple different MHC molecules (2022-10-11),

5. 11185578 - Breast and ovarian cancer vaccines (2021-11-30),

6. 11160853 - Breast and ovarian cancer vaccines (2021-11-02),

7. 10759836 - Cancer vaccine compositions and methods of use thereof (2020-09-01),

8. 10647961 - Methods and materials for expanding antigen-specific T cells in culture (2020-05-12),

9. 10556943 - HLA-DR binding peptides and their uses (2020-02-11),

10. 10293035 - Breast and ovarian cancer vaccines (2019-05-21),

11. 9060961 - Molecules and methods for treatment and detection of cancer (2015-06-23),

12. 8524491 - Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated (2013-09-03),

13. 8216789 - Diagnostic panel of cancer antibodies and methods for use (2012-07-10),

14. 7655239 - [object Object] (2010-02-02),

15. 7601697 - [object Object] (2009-10-13),

Title: Mary L Disis - Pioneering Inventor in Renton, WA

Introduction: Mary L Disis is a renowned inventor based in Renton, WA, known for her groundbreaking contributions to the field of innovation and patents.

Latest Patents: Mary L Disis holds several patents in the medical field, focusing on novel methods for cancer treatment and immunotherapy. Her recent patents include advancements in personalized medicine and targeted therapies.

Career Highlights: With a distinguished career spanning over two decades, Mary L Disis has been at the forefront of cutting-edge research in oncology and immunology. She has received numerous awards for her innovative work and has been recognized globally for her contributions to the field.

Collaborations: Mary L Disis has collaborated with leading pharmaceutical companies, research institutions, and universities to further her research and bring her inventions to market. Her collaborative efforts have resulted in transformative developments in cancer treatment.

Conclusion: Mary L Disis stands as a trailblazing inventor whose work has significantly impacted the field of oncology and personalized medicine. Her dedication to innovation and improving patient outcomes continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.